4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001753926-25-001077
Chief Financial Officer acquired 10,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Francis Knuettel II Chief Financial Officer | 2025-07-01 | Conversion | +10,000 | $10.00 | $100,000 | 10,000 | I |
| Derivatives | |||||||
| Francis Knuettel II Chief Financial Officer | 2025-07-01 | Other acquisition · Series A Convertible Preferred Stock | +10,000 | 10,000 | I | ||
| Francis Knuettel II Chief Financial Officer | 2025-07-01 | Conversion · Series A Convertible Preferred Stock | −10,000 | 0 | I | ||
Loading xslF345X05/ownership.xml…